Table 1.
Author | Year | Country | Sample size | TNM stage | Treatment | Cutoff of SMI | Endpoint | NOS |
---|---|---|---|---|---|---|---|---|
Choi[25] | 2015 | Korea | 484 | Advanced | Non-surgery | Male: <42.2 cm2/m2, female: <33.9 cm2/m2 | OS | 7 |
Park[26] | 2016 | Korea | 88 | Advanced | Non-surgery | Male: <49.18 cm2/m2, female: <31.09 cm2/m2 | OS | 7 |
Ninomiya[27] | 2017 | Japan | 112 | I–IV | Surgery | Male: <43.75 cm2/m2, female: <38.5 cm2/m2 | OS | 7 |
Okumura[28] | 2017 | Japan | 301 | I-II | Surgery | Male: <47.1 cm2/m2, female: <36.6 cm2/m2 | OS, PFS | 6 |
Bian[29] | 2018 | China | 203 | III-IV | Non-surgery | Male: <42.0 2c m2/m2, female: <36.55 cm2/m2 | OS | 6 |
EI Amrani[30] | 2018 | France | 107 | NR | Surgery | Male: <52.4 cm2/m2, female: <38.5 cm2/m2 | OS | 7 |
Sugimoto[31] | 2018 | USA | 323 | NR | Surgery | Male: <55.4 cm2/m2, female: < 38.9 cm2/m2 | OS, PFS | 6 |
Basile[32] | 2019 | Italy | 162 | Advanced | Non-surgery | Male: <53/43 cm2/m2, female: <41 cm2/m2 | OS | 6 |
Gruber[33] | 2019 | Austria | 133 | I-IV | Surgery | Male: <52.4 cm2/m2, female: <38.5 cm2/m2 | OS | 8 |
Kurita[34] | 2019 | Japan | 82 | Advanced | Non-surgery | Male: <45.3 cm2/m2, female: <37.1 cm2/m2 | OS | 8 |
Lee[35] | 2019 | Korea | 57 | Advanced | Non-surgery | NR | OS, PFS | 6 |
Naumann[36] | 2019 | Germany | 147 | I–IV | Mixed | Male: <52.4 cm2/m2, female: <38.5 cm2/m2 | OS | 7 |
Wu[37] | 2019 | China | 146 | I–IV | Mixed | Male: <36.2 cm2/m2, female: <29.6 cm2/m2 | OS | 6 |
Cho[38] | 2021 | Korea | 299 | Advanced | Mixed | Male:< 36.2 cm2/m2, female: <29.6 cm2/m2 | OS, PFS | 8 |
Hsu[39] | 2021 | USA | 136 | I-IV | NR | Male: <43.75 cm2/m2, female: <38.5 cm2/m2 | OS | 8 |
Kim[40] | 2021 | South Korea | 330 | Advanced | Non-surgery | Male: <53/43 cm2/m2, female: <41 cm2/m2 | OS | 7 |
Nakano[41] | 2021 | Japan | 55 | Advanced | Non-surgery | Male: <42.2 cm2/m2, female: <33.9 cm2/m2 | OS | 7 |
Peng[42] | 2021 | China | 116 | I-IV | Surgery | Male: <42.2 cm2/m2, female: <33.9 cm2/m2 | OS, PFS | 8 |
Uemura[43] | 2021 | Japan | 69 | Advanced | Non-surgery | Male: <42 cm2/m2, female: <38 cm2/m2 | OS | 8 |
Aziz[44] | 2022 | Netherlands | 415 | NR | Surgery | Male: <54.3/52.3 cm2/m2, female: <46.6/38.6 cm2/m2 | PFS | 6 |
NOS = Newcastle-Ottawa Scale, NR = not reported, OS = overall survival, PFS = progression-free survival, SMI = skeletal muscle index, TNM = tumor-node-metastasis.